Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Avanafil
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Avanafil 100mg tablets
0704050ACAAABAB
|
Avanafil | Avanafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1,534 |
|
Avanafil 200mg tablets
0704050ACAAACAC
|
Avanafil | Avanafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1,280 |
|
Avanafil 50mg tablets
0704050ACAAAAAA
|
Avanafil | Avanafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 450 |
|
Spedra 200mg tablets
0704050ACBBACAC
|
Spedra | Avanafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 58 |
|
Spedra 100mg tablets
0704050ACBBABAB
|
Spedra | Avanafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 37 |
|
Spedra 50mg tablets
0704050ACBBAAAA
|
Spedra | Avanafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 7 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.